KCNQ4 Gene Deafness Autosomal Dominant Type 2A Genetic Test sale cost 4400 AED
COL4A3 Gene Alport syndrome autosomal recessive Genetic Test sale cost 4400 AED COL4A3 Gene Alport syndrome autosomal recessive Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
CCDC50 Gene Deafness Autosomal Dominant Type 44 Genetic Test sale cost 4400 AED CCDC50 Gene Deafness Autosomal Dominant Type 44 Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

KCNQ4 Gene Deafness Autosomal Dominant Type 2A Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The “KCNQ4 Gene Deafness Autosomal Dominant Type 2A Genetic Test” is a specialized diagnostic tool designed to identify mutations in the KCNQ4 gene, which are known to cause Autosomal Dominant Non-Syndromic Hearing Loss (ADNSHL) type 2A. This form of hearing loss is characterized by its inheritance pattern, where only one copy of the mutated gene from an affected parent can lead to the condition in the offspring, showcasing a dominant inheritance pattern.

The KCNQ4 gene plays a critical role in the function of inner ear cells by contributing to the proper creation of potassium channels. These channels are essential for the conversion of sound waves into electrical signals that the brain can interpret as sound. Mutations in the KCNQ4 gene disrupt this process, leading to progressive hearing loss.

The test, offered by DNA Labs UAE, utilizes advanced genetic sequencing technologies to scrutinize the KCNQ4 gene for any abnormalities that might be responsible for hearing loss. By providing a precise genetic diagnosis, the test enables targeted management and counseling for affected individuals and their families. It is particularly beneficial for early detection, allowing for timely intervention strategies that can significantly improve the quality of life for those with the condition.

Priced at 4400 AED, this genetic test represents a crucial investment for families with a history of hearing loss, offering them valuable insights into their genetic makeup and the potential for hereditary hearing loss conditions. Conducted in the state-of-the-art facilities of DNA Labs UAE, the test adheres to high standards of accuracy, confidentiality, and ethical considerations, ensuring reliable results for patients seeking clarity about their genetic health.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

KCNQ4 Gene Deafness Autosomal Dominant Type 2A Genetic Test

Are you or a loved one experiencing deafness? DNA Labs UAE offers the KCNQ4 Gene Deafness Autosomal Dominant Type 2A Genetic Test to help diagnose and understand this condition. Read on to learn more about the test, its components, cost, symptoms, diagnosis, and more.

Test Details

The KCNQ4 gene is responsible for encoding a protein called potassium voltage-gated channel subfamily Q member 4. This protein plays a crucial role in the functioning of the inner ear, specifically in the maintenance of the cochlear hair cells that are involved in hearing. Deafness caused by mutations in the KCNQ4 gene is known as autosomal dominant type 2A deafness. This means that a person only needs to inherit one copy of the mutated gene from either parent to develop the condition. This form of deafness typically affects both ears and can be present from birth or develop later in life.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that allows for the rapid and cost-effective analysis of multiple genes simultaneously. In the context of KCNQ4 gene deafness, NGS genetic testing can identify any mutations or variations in the KCNQ4 gene that may be responsible for the condition. By identifying the specific mutation in the KCNQ4 gene, NGS genetic testing can provide a definitive diagnosis for individuals with autosomal dominant type 2A deafness. This information can be useful in understanding the underlying cause of the deafness and may help guide treatment and management options.

It’s important to note that genetic testing for KCNQ4 gene deafness is typically performed in a clinical setting by healthcare professionals trained in genetics. The results of the genetic test should be interpreted by a qualified geneticist or genetic counselor, who can provide appropriate counseling and support based on the findings.

Test Components and Price

Test Name: KCNQ4 Gene Deafness Autosomal Dominant Type 2A Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Report Delivery

Report delivery typically takes 3 to 4 weeks.

Method

The KCNQ4 Gene Deafness Autosomal Dominant Type 2A Genetic Test utilizes NGS Technology.

Test Type

The test is categorized under Ear Nose Throat Disorders.

Referring Doctor

The test is typically conducted by an ENT Doctor.

Test Department

The test is conducted in the Genetics department.

Pre Test Information

Prior to the test, it is important to provide the clinical history of the patient who is going for the CATSPER2 Gene Deafness and male infertility, CATSPER2 related NGS Genetic DNA Test. A Genetic Counselling session may be conducted to draw a pedigree chart of family members affected with CATSPER2 Gene Deafness and male infertility, CATSPER2 related NGS Genetic DNA Test gene CATSPER4.

Interested in getting the KCNQ4 Gene Deafness Autosomal Dominant Type 2A Genetic Test? Contact DNA Labs UAE today to schedule an appointment and take the first step towards understanding and managing your condition.

Test Name KCNQ4 Gene Deafness autosomal dominant type 2A Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Ear Nose Throat Disorders
Doctor ENT Doctor
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for CATSPER2 Gene Deafness and male infertility, CATSPER2 related NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CATSPER2 Gene Deafness and male infertility, CATSPER2 related NGS Genetic DNA Test gene CATSPER4
Test Details

The KCNQ4 gene is responsible for encoding a protein called potassium voltage-gated channel subfamily Q member 4. This protein plays a crucial role in the functioning of the inner ear, specifically in the maintenance of the cochlear hair cells that are involved in hearing.

Deafness caused by mutations in the KCNQ4 gene is known as autosomal dominant type 2A deafness. This means that a person only needs to inherit one copy of the mutated gene from either parent to develop the condition. This form of deafness typically affects both ears and can be present from birth or develop later in life.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that allows for the rapid and cost-effective analysis of multiple genes simultaneously. In the context of KCNQ4 gene deafness, NGS genetic testing can identify any mutations or variations in the KCNQ4 gene that may be responsible for the condition.

By identifying the specific mutation in the KCNQ4 gene, NGS genetic testing can provide a definitive diagnosis for individuals with autosomal dominant type 2A deafness. This information can be useful in understanding the underlying cause of the deafness and may help guide treatment and management options.

It’s important to note that genetic testing for KCNQ4 gene deafness is typically performed in a clinical setting by healthcare professionals trained in genetics. The results of the genetic test should be interpreted by a qualified geneticist or genetic counselor, who can provide appropriate counseling and support based on the findings.

SKU: TEST-2683 Category:

Related products